Skip to content

Study Of Factors Favoring The Onset Of Novo Atrial Fibrillation In The Immediate Aftermath Of Coronary Artery Bypass Surgery

STUDY OF FACTORS FAVORING THE ONSET OF NOVO ATRIAL FIBRILLATION IN THE IMMEDIATE AFTERMATH OF CORONARY ARTERY BYPASS SURGERY

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02042547
Enrollment
100
Registered
2014-01-23
Start date
2010-09-30
Completion date
Unknown
Last updated
2014-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Graft With or Without ECC

Brief summary

Before la surgery: Transthoracic cardiac echography will be done systematically, to measure among other things the size of the left atrium. During surgery: Surgery under extracorporeal circulation: tissue samples will be harvested from the right atrium (one before clamping of the aorta (T0= pre-ischemia sample), immediately before declamping of the aorta (T1= post-ischemia sample). Surgery without extracorporeal circulation: tissue samples from the right atrium before CABG (T0) and a second sample after CABG (T1). In parallel with the harvesting of cardiac tissue, blood samples will be taken at different times (H0, H3, H24) to correlate tissue data with systemic data. These will be taken by the anesthetists. After the surgery: Holter ECG will be set up for 7 days of continuous recording. Each patient will fill in an observation notebook. The biological samples will be analysed immediately and the biological data obtained will be recorded in the observation notebook.

Interventions

OTHERTissue samples from the right atrium
OTHERBlood samples

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Patients who have provided written informed consent * Patients covered by the national health insurance scheme * Heart surgery (CABG) with and without extracorporeal circulation * Elective or deferred emergency surgery * Consecutive patients aged less than 80 years

Exclusion criteria

* Patients less than 18, under guardianship * Patients over 18, under guardianship * Patients who do not understand the study data * Patients undergoing emergency surgery who therefore cannot be given or understand the explanations for the study (patients in shock, intubated patients with mechanical ventilation) * History of heart surgery * History of AF * Treatment with Cordarone.

Design outcomes

Primary

MeasureTime frame
Onset or a de novo episode of atrial fibrillation during the 7 days following heart surgery7 days post-surgery

Secondary

MeasureTime frame
Markers of ischemia: circulating Troponin I before the surgery and at the end of the procedureBaseline and at the end of surgery (15 minutes after unclamping when extracorporeal circulation)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026